Key terms
About Biora Therapeutics, Inc. 7.25% 01-DEC-2025
Sector
Health Technology
Industry
Biotechnology
Home page
ISIN
US74319FAB31
FIGI
BBG00YDFX9H3
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
Related bonds
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.